Skip to page content

Objective Analysis. Effective Solutions.

Site-wide navigation

About RAND
RAND Campaign
Press Room
Careers

Research
Research Areas
Trending Topics
All Topics Browse Reports
Research Divisions
Research Departments
Latest Insights
Reports
Preparing the Workforce for AI: Insights for Civilian and Military Leaders

China's Use of Generative AI and Social Bots
Commentary and Articles
India Can Weather Its Bangladesh Headache

No Easy Answers: America's Limited Choices in Dealing with North Korea
Multimedia
The Math Equity Equation

The Policy Currents Podcast
Policy Experts
All Experts

Spotlight
- Derek Grossman @DerekJGrossman
  
  Commentary:
  
  India Can Weather Its Bangladesh Headache
- Raphael S. Cohen
  
  Commentary:
  
  October 7th and the Limits of Diplomacy
By Research Area
Capabilities
Drawing upon decades of experience, RAND provides research services, systematic analysis, and innovative thinking to a global clientele that includes government agencies, foundations, and private-sector firms.
Capabilities Overview

RAND Solutions

Who We Work For

Public Sector

Philanthropic Sector

Private Sector

Work with Us

Explore Business Contacts

About RAND Research

Disciplinary Expertise

Quality Standards

Methodological Innovation
Featured Solutions
Getting to Know Military Caregivers and Their Needs

Managing Escalation in Crisis and War

Assessing and Articulating the Wider Benefits of Research

Improving Access to Early Childhood Education
Graduate School
The Pardee RAND Graduate School (PardeeRAND.edu) is home to the only Ph.D. and M.Phil. programs offered at an independent public policy research organization—the RAND Corporation.
Featured Video: Campus Tour

Student Life at Pardee RAND
Student Spotlight
- Noah Johnson
  
  Assistant Policy Researcher, RAND; Ph.D. Candidate, Pardee RAND Graduate School
- Brian Mills
  
  Assistant Policy Researcher, RAND; Ph.D. Student, Pardee RAND Graduate School
About

中文(简体)
العربية
Cart

Site-wide Search

RAND
Topics
>Hepatitis C

Hepatitis C

Hepatitis C

Related Topics

Infectious Diseases

Explore RAND’s Work on this Topic

Skip to results

Search by keyword

Content Type
- Journal Article (18)
- Commentary (4)
- Report (3)
- News Release (2)
- Project (1)
Region
Most relevant regions
- Americas (5)
- North America (5)
- United States (5)
- California (4)
- Pacific States (4)
- Southwestern States (4)
- Los Angeles (3)
- Europe (2)
- United Kingdom (2)
- France (1)
Date
- Last 30 days
- Last 90 days
- Last year
- Last two years
to

28 Results

number of items to display at a time

Error

Journal Article

Feb 1, 2024

Patient Perspectives on Solid Organ Transplantation from Donors with Hepatitis C Viremia to Recipients Without Hepatitis C Viremia

We conducted in-depth, semi-structured interviews with organ transplant recipients without hepatitis C viremia who received organs from donors with hepatitis C viremia to assess their experiences and perspectives.
Journal Article

Mar 29, 2022

Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns

US hepatitis C viral infections among pregnant women grew fastest among White and American Indian/Alaska Native people without a 4-year degree.
Journal Article

Jun 3, 2020

Assessing and Expanding the Evidence Base for Project ECHO and ECHO-Like Models: Findings of a Technical Expert Panel

Building a strong evidence base will help leverage the innovative aspects of EELM by better understanding how, why, and in what contexts EELM improve care access, quality, and delivery, while also improving provider satisfaction and capacity.
Commentary

May 21, 2020

Subscription Models for Prescription Drugs: The Motivation, Potential, and Limitations of a New Payment Model

The authors argue that, conceptually, the main advantage of subscription models over traditional prescription drug payment arrangements is that they could reduce some sources of uncertainty in spending for payers and in revenue for manufacturers.
Report

Jun 18, 2019

Identifying Safety-Net Resources at Health Centers to Prevent Infectious Disease Transmission Resulting from the Opioid Epidemic

This study highlights factors that affect Community Health Centers' ability to reduce infectious disease transmission related to the opioid epidemic.
Journal Article

Mar 13, 2019

A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C

The 2010 reformulation of Oxycontin to prevent abuse of the drug (by making it crush-proof and therefore impossible to dissolve in liquid) had the unintended effect of driving some users to switch to heroin, which contributed to a dramatic rise in Hepatitis C.
Commentary

Feb 20, 2019

Opioids and a Crisis of Unintended Consequences

The pain medicine OxyContin was reformulated in 2010 to make it more difficult to crush or dissolve. But this had unintended consequences, including a rise in hepatitis C infections as drug abusers switched from taking OxyContin to injecting heroin.
News Release

Feb 4, 2019

Reformulation of OxyContin to Discourage Abuse Linked to Higher Rates of Hepatitis C Infections

To discourage drug abuse, the pain medicine OxyContin was reformulated in 2010, making it difficult to crush or dissolve. This led to a large rise in hepatitis C infections as drug abusers switched from OxyContin to injectable heroin.
Journal Article

Jun 6, 2017

The Association Between Implementation Strategy Use and the Uptake of Hepatitis C Treatment in a National Sample

Veterans Health Administration sites that used more ERIC-recommended implementation strategies delivered more evidence-based Hepatitis C treatments.
Project

Aug 23, 2016

Understanding Physicians' Decision Making Process Concerning Hepatitis-C Treatment

A wide variety of factors influence physicians’ treatment decisions for patients with hepatitis C. These include clinical factors, comorbidities, population groups, sociodemographic factors, and patient behaviour, as well as health financing and cost-effectiveness, access to care, and more.
Report

Aug 19, 2016

Hepatitis C: Understanding factors that influence the physicians' treatment decisions

A study investigating the decisionmaking process undertaken by physicians when prescribing treatment for Hepatitis C and the comparative influence and importance of specific factors and combinations of factors.
Commentary

Jun 22, 2015

Paying for Pricey Medications: Debt Financing Options Could Provide a Solution

A new approach may be needed to finance an emerging breed of expensive but highly effective pharmaceuticals and vaccines. The health care industry could learn from other industry approaches such as equipment leases or supplier-financed credit.

Previous
1
2
3
Next

Oops! An unexpected error has occurred.

Please try again. If you see this message repeatedly, there may be a problem with site functionality at this time. Thanks for your patience while we work to resolve the problem.

Subscribe to the Policy Currents newsletter

Email

See all newsletters

About

RAND is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest.

RAND History
Diversity, Equity, and Inclusion
Leadership
Research Integrity
Career Opportunities

Connect

Contact Us
Locations

I am interested in

Jobs at RAND
Media Resources
Congressional Resources
Doing Business with RAND
Supporting RAND
Educational Opportunities
Alumni Association

Follow

RAND on LinkedIn
RAND on Twitter
RAND on Facebook
RAND on YouTube
RAND on Instagram

Stay Informed

Subscribe to the Policy Currents newsletter for RAND insights on the issues that matter most.

Stay Informed

Policy Currents newsletter

Get updates from RAND delivered straight to your inbox.

Email

View all email newsletters

Resources

Multimedia
Latest Reports
Browse by Author
RAND Classics
Databases and Tools

Site Information

Site Map
PRIVACY POLICY
Support Policy
Feedback
Help

1776 Main Street
Santa Monica, California 90401-3208

RAND® is a registered trademark. © 2024 RAND Corporation. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.